FGL1 and hepatocellular carcinoma: To examine whether the potential mechanism underlying the therapeutic action of sorafenib differed depending on the basal level of FGL1 in HCC cell lines, we measured the levels of proteins related to cell proliferation, autophagy, and apoptosis by western blotting (Figure 3A).